Ryzneuta® (Efbemalenograstim alfa-vuxw), sold under the brand name 亿立舒® in china, is a leukocyte growth factor used for reducing the incidence of infection, as manifested by febrile neutropenia (FN), in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer ...